Chemical Structure (Duloxetine 01)
Duloxetine Capsule, Delayed Release Pellets
Product Images NDC 63629-1991
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Duloxetine (NDC 63629-1991). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Duloxetine 02)
This is a chart that shows the proportion of patients with relapse over time in days, based on two treatments: Placebo and Duloxetine delayed-release capsules. The chart displays a range of 0-10% for the proportion of patients experiencing relapse. The x-axis shows the time in days from randomization, starting from 0 and going up to 250 days.*
Figure 2 (Duloxetine 03)
Figure 3 (Duloxetine 04)
Figure 4 (Duloxetine 05)
Figure 5 (Duloxetine 06)
Figure 6 (Duloxetine 07)
Figure 8 (Duloxetine 08)
Figure 9 (Duloxetine 09)
The text describes a chart showing the percentage of patients improved after taking either a placebo or DUL medication. The chart includes data points for each treatment option at various levels of pain improvement as well as a graph showing the percent improvement in pain from baseline.*
Figure 10 (Duloxetine 10)
The given text describes a chart or graph indicating the percentage of patients improved in response to the drug DUL60/120 mg once daily compared to placebo in terms of pain relief. The chart also displays percent improvement in pain from baseline BOCF (baseline observation carried forward) using different values such as 0, 20, 30, 50, 60, >70, 80 and 60 10D for the drugs.*
Label (Lbl636291991)
This is a medication called Duloxetine Delayed-Release Capsules. Each capsule contains 30mg of Duloxetine Hydrochloride. It is important to keep this medication out of reach of children and stored at a controlled room temperature of 20-25°C. The medication should also be kept in a container with a child-resistant closure. The package contains 90 capsules and requires a prescription.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
